William Blair analyst Sami Corwin has maintained their bullish stance on ZVRA stock, giving a Buy rating on October 7. Sami Corwin has given …
Buy Rating Affirmed for Zevra Therapeutics Based on Strong NPV and Future Market Potential
view original post